Cardiovascular trials with SGLT2 inhibitors – a primer to survive in the jungle

Authors

Mattia Arrigo, SWITZERLAND
Lars Christian Huber, Stadtspital Zürich Triemli | SWITZERLAND

DOI

10.4414/cvm.2022.02228

Content

PDF

Metadata

JATS XML

Icon of Creative Commons Attribution 4.0 International license Licensed under a Creative Commons Attribution 4.0 International license.

Article

Title: Cardiovascular trials with SGLT2 inhibitors – a primer to survive in the jungle
Authors: Arrigo, Mattia; Huber, Lars Christian
DOI: 10.4414/cvm.2022.02228
Published online: 2022-09-01

Toggle